Mind Medicine (MindMed) Inc. financial data

Symbol
MNMD on Nasdaq
Location
One World Trade Center, Suite 8500, New York, NY
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 605 % +55.8%
Debt-to-equity 29.3 % -21.7%
Return On Equity -48.2 % +48.3%
Return On Assets -37.3 % +45.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 75.4M shares +4.86%
Common Stock, Shares, Outstanding 75.1M shares +82.7%
Entity Public Float 515M USD +268%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 70.5M shares +79.9%
Weighted Average Number of Shares Outstanding, Diluted 70.5M shares +79.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 65.3M USD +25.3%
General and Administrative Expense 38.6M USD -7.48%
Operating Income (Loss) -104M USD -10.7%
Net Income (Loss) Attributable to Parent -109M USD -13.5%
Earnings Per Share, Basic -1.54 USD/shares +36.9%
Earnings Per Share, Diluted -1.54 USD/shares +36.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 274M USD +175%
Assets, Current 282M USD +171%
Goodwill 19.9M USD 0%
Other Assets, Noncurrent 613K USD +174%
Assets 302M USD +143%
Accounts Payable, Current 2.01M USD -51.4%
Accrued Liabilities, Current 12.8M USD +10.3%
Liabilities, Current 38.8M USD +20.5%
Other Liabilities, Noncurrent 15K USD -98.6%
Liabilities 60.7M USD +30.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 819K USD +139%
Retained Earnings (Accumulated Deficit) -399M USD -37.5%
Stockholders' Equity Attributable to Parent 241M USD +209%
Liabilities and Equity 302M USD +143%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.6M USD -24.5%
Net Cash Provided by (Used in) Financing Activities 169M USD +28930%
Common Stock, Shares, Issued 75.1M shares +82.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 153M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 434K USD
Deferred Tax Assets, Valuation Allowance 69.9M USD +37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -108M USD -12.7%
Deferred Tax Assets, Operating Loss Carryforwards 42.5M USD +34.6%
Unrecognized Tax Benefits 0 USD
Amortization of Intangible Assets 527K USD -83.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 16.9M USD +11.4%
Interest Expense 2.28M USD +148%